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Objectives. The aim was to evaluate survival and success rates, soft tissue health, and radiographic marginal bone loss (MBL) of
zirconia implants placed in the esthetic and posterior areas of the jaws and in associationwithmultiple or single implant restorations
after at least 6 months of definitive restoration.Material and Methods. 35 one-piece zirconium implants were utilized for single or
partially edentulous ridges rehabilitation. All implants received immediate temporary restorations and six months after surgery
were definitively restored. Every 6 months after implant placement, a clinical-radiographic evaluation was performed. For each
radiograph, the measurements of MBL were calculated. Results. The results showed that the mean MBL at 48-month followup was
1.631mm. The mean MBL during the first year of loading was not more significant for implants placed in the first molar regions
than for those positioned in other areas. Moreover, no differences in marginal bone level changes were revealed for multiple and
single implants, whereas MBL in the first year was observed to be slightly greater for implants placed in the maxilla than for those
placed in the mandible. Conclusion. Zirconia showed a good marginal bone preservation that could be correlated with one-piece
morphology and characteristics of zirconia implants.
1. Introduction
Theuse of endosseous implants achieves predictable results in
terms of survival and success rates of oral rehabilitation [1].
More recently, greater interest is directed towards esthetics
of the prosthetic rehabilitations. Successful esthetic results
of dental implant placement require knowledge of essential
biological concepts and skill in different surgical techniques
[2].
Anyway, the surgical techniques or prosthetic [3] solu-
tions by now proposed are not always sufficient to achieve
long-term esthetic results; in fact, it was demonstrated that
periimplant soft tissues tend to recede after positioning a
definitive prosthetic restoration [4]. In order to avoid gray-
ish transparency of titanium implants through soft tissues,
ceramic materials were tested. All-ceramic dental implants
were introduced in dental implantology as an alternative
to titanium implants. Another reason to find an alternative
material to titanium was sensibilization, possible release of
metallic ions, and allergy to this material, as reported in some
studies [5, 6]. Alumina was one of the first ceramic materials
used but because of its hardness combined to a low flectural
and fracture strength poor long-term results were achieved
and this material was abandoned [7].
More recently, research was oriented towards new gen-
eration ceramic materials such as zirconia, which has more
favorable mechanical properties (high flexural strength 900–
1200Mpa, hardness 1200 Wickers, and Weibull modulus 10–
12). In addition, zirconia has a high biocompatibility and low
plaque adhesion [8, 9] and several animal studies showed
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Figure 1: Implant characteristics.
long-term osseointegration of zirconia dental implants and
a bone-to-implant contact similar to titanium [10–13]. Due
to its favorable aesthetic characteristics, zirconia can be
successfully used in case of thin biotypes or soft tissue
recessions.
Moreover, studies [4] demonstrate that perimplant soft
tissues tend to recede after positioning a definitive prosthetic
restoration.
The purposes of this study were to evaluate survival and
success criteria of endosseous one-piece yttrium-stabilized
zirconia dental implants during a follow-up period of 12–
48 months after insertion, appreciate periimplant soft tissue
health, and consider periimplant marginal bone remodeling.
2. Materials and Methods
2.1. Implant System. In this study, WhiteSky dental implant
(Bredent, Senden, Germany) was used. WhiteSky is a one-
piece implant characterized by a conical body with double
threads and rounded apex and is made of sintered and
yttrium-stabilized zirconium oxide. The endosseous implant
surface is treated with a sandblasting process that determines
microscopical surface characteristics of medium rugosity
(𝑅
𝑎
= 0.9-1m) similar to those of last generation titanium
implants, whereas in the gingival area the implant features a
machined neck with a height of 2mm.The abutment surface
is also machined and has a length of 6.8mm (Figure 1).
2.2. Patients Selection. For this study, patients were selected
according to the following criteria.
All implant sites should present adequate bone volume
(height > 8mm, thickness > 4mm).
Absence of systemic contraindications (metabolic dis-
orders, immunodeficiency, hemathological diseases, neo-
plastic diseases, bisphosphonates history, and smoking >
10 cigarettes/day) is evident.
Absence of local contraindications (head and neck radio-
therapy, poor oral hygiene, active periodontal disease, and
parafunctions) is evident.
Exclusion criteria were determined by the presence of
one or more of the systemic or local contraindications
plus patients aged <18 years, patients with total edentulism,
patients with detected bruxism and regenerative procedures
previous to implant insertion.
Starting from January 2007, and recruited in a period of
one year, 13 patients were included in the study. The data
were recorded to July 2012 when the implants had a minimal
observation period of 4 years.
Average age was 60 years (range from 38 to 75). Twelve
patients were men and one was woman.
35 one-piece endosseous dental implants made of sinter-
ized and yttrium-stabilized zirconiumoxidewere used for the
rehabilitation of single tooth or partially edentulous ridge.
Three patients, with seven implants placed, were dropped
out the protocol because they did not attend to followup.
2.3. Presurgical Protocol. Prior to surgery patients had to:
(i) take orthopantomograph or standardized endoral
radiographic,
(ii) take Ct san,
(iii) undergo professional oral hygiene (7 days before
surgery),
(iv) start mouth rinsing twice a day with chlorhexidine
0.2% (Corsodyl, Glaxo, UK) 2-3 days before surgery
and continue for 2 weeks after surgery,
(v) take antibiotic prophylaxis with amoxicillin + clavu-
lanic acid (Laboratori Eurogenerici, Milano, Italy) 2 g
1 hour prior to surgery.
2.4. Surgical Protocol. All patients were previously informed
about zirconia implants and possible alternatives and gave a
written consent.
Implants were positioned according to the guide of a
surgical mask obtained by a diagnostic wax-up. After reflect-
ing a full thickness flap, implant site preparation was per-
formed in order to leave implant abutments with machined
neck to heal transmucosally, whereas implant body rough
surface was left completely inside the bone. All implants
were inserted using both a surgical motor and manually.
In case of fenestrations or dehiscences, regenerative proce-
dures by resorbablemembranes (Bio-Gide, Geistlich Pharma,
AG Wolhusen, Switzerland) and bone substitutes (Bio-Oss,
Geistlich Pharma, AG Wolhusen, Switzerland) were per-
formed. The implant stability was evaluated with the torque
at insertion. Flapswere suturedwith 4/0monofilament suture
(Premilene, Braun, Melsungen, Germany). When necessary,
flaps were released through periosteal incisions in order to
attain a primary wound closure. Patients were given oral
hygiene suggestions andwere instructed not to chew or eat on
implant site until healing was completed. Antibiotic therapy
and chlorhexidine mouth rinses were continued for 7 days
and Paracetamol 500mg (Tachipirina,Angelini, Roma, Italy)
was prescribed and adopted by the patients when needed.
Sutureswere removed 7 days after surgery. Follow-up controls
were programmed after 1 week, 2 weeks, and subsequently
once a month for the following 6 months.
2.5. Prosthetic Protocol. Immediately after surgery, implant
abutments were prepared in order to correct axis and length
using double diamond burs suited for zirconia (Eterna, Bre-
dent, Senden, Germany), and water cooling and temporary
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Figure 2: Standardized periapical radiographs were obtained using
the Rinn alignment system with customized silicone bite.
restorations were relined with acrylic resin. Single implants
were cemented avoiding centric and eccentric contacts and
stabilized to the adjacent teeth using composite wings for
at least 6–8 weeks in order to reduce the risk of failure
due to micromovements. Multiple implants were connected
together by a provisional restoration and when possible
excluded from occlusal contacs.
Sixmonths after surgery, implants were finally restored by
all ceramic zirconia crowns or bridgesmade with CAD-CAM
system (LAVA, 3M ESPE, St. Paul, MN) and cemented with
a glass ionomer cement (GC Fuji, CEM GC America, Alsip,
IL).
2.6. Follow-Up Protocol. The protocol included clinical-
radiographic examinations every 6 months after surgery as
follows.
Clinical evaluation (presence or absence of mobility, self-
reported pain, or paresthesia and assessment of the integrity
of the final prosthesis) is evident.
Periodontal evaluation with calibrated probe (Hu-Friedy,
N. Rockwell, Chicago, IL) in order to evaluate probing pocket
depth (PPD), plaque index (PI), and bleeding on probing
(BOP) is evident.
Survival criteria were identified as the survival of loaded
functionalized asymptomatic implants.
Success criteria were formulated according to the follow-
ing parameters:
(1) mobility is not present,
(2) self-reported pain or paresthesia is not present,
(3) periimplant radiolucency is not present,
(4) periimplant marginal bone loss inferior to 1.5mm
during the first year in function and an annual bone
loss thereafter are not exceeding 0.2mm.
2.7. Radiographic Evaluation. According to this protocol,
standardized periapical radiographs should be taken at the
time of implant placement and 6 months, 12 months, 24
months, 36 months, and 48 months after, using a customized
bite recordmade withOrthogum (Zhermack, Badia Polesine,
Rovigo, Italy) on a rinn XCO Ring positioner (Dentsply,
Constanz, Germany) (Figure 2). Radiographs were acquired
and converted into digital images with a scanner (Epson
Figure 3: X-ray picture 12 months after surgery. The blue lines
indicate the implant length; the red lines indicate the periimplant
bone levels.
1680 Pro, Seiko Epson Cooperation, Nagano, Japan) and
saved in .JPG format. Each image was processed with a
specific software (CorelDraw 10.0, Corel Corp and Coral Ltd,
Ottawa, Canada) and analyzed at ×20 magnification in order
to calculate marginal bone loss. Mesial and distal marginal
bone levels of all the implants were determined at baseline
and recall evaluations. The known length of the implant
(measured from the implant shoulder to the implant apex)
according to the manufacturer was used as reference point.
The distance from implant shoulder to crestal bone level was
measured on the magnified images (Figure 3). To account for
variability, the implant dimension (length) on the magnified
X-ray was measured and compared to the real dimension,
and ratios were calculated to adjust for distortion. Bone levels
changes were calculated at the distal andmesial surfaces of all
implants by applying the distortion coefficient.
2.8. Statistical Evaluation. Data analysis was performed with
descriptive statistics. Mean and standard deviation values
were recorded and the paired Student’s 𝑡-test was used for
comparison of mean values between groups (multiple-single
implants; implants placed in maxilla or mandible; implants
placed in esthetic or posterior regions of the jaws). Confi-
dence interval was set at 99% mean for all measurements.
Statistically significant differences were set at 𝑃 = .01.
3. Results
The data reported in this study refer exclusively to 28
implants.
Mean implant diameter was 4mm and mean implant
length was 12.3 ± 1.28mm. The range of length for the
implants considered in this study was from 10 to 14mm.
20 implants were placed in the maxilla, whereas 8
implants were inserted in the mandible.
Six implants replaced missing first molars both in
mandible and maxilla, and the remaining implants were
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Table 1: Survival and success rates.
6 months 12 months 18 months 24 months 36 months 48 months
Success criteria
Mobility − − − − − −
Paresthesia − − − − − −
Radiolucency − − − − − −
MBL < 1.5 mm (1∘ year) + <0.2mm (following years) + + + + + +
Survival criteria
Loaded functionalized asynthomatic implants + + + + + +
(+) present/(−) absent.
placed in other regions (from 1.5 to 2.5 and from 3.5 to 4.5).
20 implants were used for multiple teeth replacement.
All implants were immediately restored with temporary
acrylic resin crowns or bridges (multiple implants were
splinted together by provisional restoration), and defini-
tive restorations were positioned after a healing time of 6
months. The implants were finally restored by all ceramic
zirconia crowns or bridges made with CAD-CAM system, as
described.
During the 48months of followup, no implant failure was
reported, no pain, and no paresthesia, and at the radiographic
evaluation periimplant radiolucency was present in none of
the implants.
Survival and success rates within follow-up period were
therefore 100% (Table 1).
Every 6 months after the final prosthetic rehabilitation,
periodontal indexes were registered for each patient at each
implant site (plaque index, bleeding on probing, probing
pocket depth, and implantmobility), and standardized radio-
graphs were taken using the long-cone paralleling technique.
The periodontal indexes are reported in Table 2.
Radiographic evaluation indicated that mean marginal
bone loss was 1.38 ± 0.02mm 6 months after implant inser-
tion; 0.41 ± 0.05mm 6 months after prosthetic finalization
except for 2 sites where it resulted as 1.5 ± 0.06mm. A
minimal bone remodelling with a further marginal bone loss
of −0.23mm, 0.021mm at 36 months, and 0.05 at 48-month
followup was observed. The mean marginal bone loss at 48
months of followup was 1.631mm.
For implants placed in the maxilla, the average marginal
bone loss from baseline to 6 months was 1.37 ± 0.27mm;
from 6 to 12 months was 0.677 ± 0.7mm; from 12 to 24
months was −0.078 ± 0.51mm; from 24 to 36 months was
0.021 ± 0.39mm (Figures 4 and 5). For implants placed in
the mandible, the radiographically determined mean MBL
amounted to 0.59 ± 0.73mm during the first year of loading
while no MBL change data were reported after first year in
function.
The marginal bone loss during the first year of loading
was more significant for implants placed in maxilla than for
those positioned in the mandible (𝑃 < .019).
The MBL changes from prosthetic restoration to 1 year
of loading were 0.445 ± 0.87mm for implants placed in the
first molar region and 0.4 ± 0.7mm for implants placed in
other regions. After 4 years of function, the MBL change
Figure 4: X-ray picture 24 months after surgery.
Figure 5: X-ray picture 48 months after surgery. No differences in
marginal bone level changes can be observed from 12 to 48 months
after surgery.
increased, respectively, by 0.02mm and 0.169mm. The dif-
ference between the two groups at 4 years was not statistically
significant.
It was investigated that from baseline to 48 months after
surgery, the mean bone resorption values were +1.2081mm
for multiple implants and +1.2088mm for single implants.
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Table 2: Periodontal indexes.
Months after implant insertion
Periodontal Indexes 6 months 12 months 18 months 24 months 36 months 48 months
PI 1 0.5 0.75 0.5 0.43 0
BOP 1 0.25 0.5 0.5 0.86 0.15
PPD (mm)
MV 4 (±0.7) 3 (±0.8) 3.5 (±1.3) 2.75 (±0.5) 3.9 (±1.28) 3.9 (±0.7)
V 2.5 (±0.7) 2.75 (±0.5) 3 (±0.8) 2.25 (±0.9) 2.7 (±0.8) 2.43 (±0.5)
DV 3.5 2.75 (±0.5) 3.5 (±1) 2.25 (±0.5) 3.3 (±0.9) 2.71 (±0.5)
MP 3 3.25 (±1.25) 4 (±0.8) 3.5 (±1.3) 3.4 (±0.8) 3.9 (±0.7)
P 2 3 2.25 (±0.9) 2.5 (±1.3) 2.9 (±1.1) 2.6 (±0.8)
DP 3 2.75 (±0.5) 3 (±0.8) 3.25 (±1.3) 3.5 (±1.2) 3.6 (±0.8)
PPD (mean) 3.0 2.917 3.208 2.75 3.283 3.19
The difference between the two groups was not statistically
significant.
4. Discussion
Several studies in animal models showed successful osseoin-
tegration of zirconia dental implants under both unloaded
and loaded conditions and bone-to-implant contact values
similar to those of titanium. Scarano et al. [8] investigated
the bone response to 20 YTZP implants inserted in the tibiae
of five rabbits. According to the authors, all implants were
osseointegrated without signs of inflammation or mobility.
The mean BIC was calculated to be 68%.
Absence of signs of marginal bone loss around implants
surface indicatesmaintained integration between the implant
fixture and the surrounding bone. However, the finding of
periimplant bone remodelling must be carefully considered
because the marginal bone loss which may be detected
around implants after beginning of function should be
distinguished from the bone loss that is affected by one or
more of the following factors: (1) traumatic surgical technique
[14]; (2) excessive loading conditions [15]; (3) location, shape,
and size of the implant abutment microgap and its microbial
contamination [16]; (4) biologic width and soft tissue consid-
erations [17]; (5) periimplant inflammatory infiltrate [18]; (6)
implant and prosthetic components micromovements [19];
(7) repeated screwing and unscrewing [20]; (8) implant-neck
geometry [21]; and (9) infectious process [22].
According to several studies investigating criteria for
implant treatment success [23, 24], a marginal bone loss of
1.5mm during the first year in function and an annual bone
loss not exceeding 0.2mm thereafter is considered acceptable.
Bra¨gger et al. [25] defined a radiographic criterion for implant
success, a perimplant bone resorption below the limits of 0.9
to 1.6mm during the first year in function.
The results of this study showed a mean marginal bone
loss of 1.38mm 6 months after implant insertion; 0.41mm
from 6 to 12 months, −0.23mm from 12 to 24 months,
0.021mm from 24 to 36 months; 0.05mm from 36 to 48
months. The mean marginal bone loss at 48 months of
followup was 1.631mm.
In the study, it was observed that marginal bone loss in
the first year is slightly greater for implants placed in the
maxilla than for those placed in the mandible. These data
could be explained by the fact that there are differences in
the remodelling capacity and rate between maxillary and
mandibular bone also due to the different bone quality and
density in the different sites.
Periimplant bone level changes during the first year of
loading were not more significant for implants placed in the
first molar regions than for other areas. The variation from
final prosthetic restoration up to 1 year of loading was 0.445±
0.87mm for implant placed in the firstmolar region and 0.4 ±
0.7mm for implants placed in other regions. After 4 years
of function, the MBL change had increased, respectively, to
0.02mm and 0.169mm.
No differences in marginal bone level changes were
observed betweenmultiple and single implants since baseline
to 4 years after surgery; themean bone resorption values were
1.2081mm for multiple implants and 1.2088mm for single
implants.
Greater bone loss occurs during the first year of function,
and it is related to maturation of bone after the surgery and
adaption of bone to withstand functional forces. In this study,
the values of marginal bone loss were within the limits of
0.9 to 1.6mm, considered to be acceptable for the first year
of loading. From 12 to 24 months after implant positioning,
an improvement of MBL values was observed probably due
to the formation of new bone trabeculae as a result of
maturation of bone. After the second year of functioning, the
annual amount of bone loss was <0.2mm.
A large number of studies evaluated the causes of early
marginal bone loss around implants. Abrahamsson and
Berglundh [26] considered the effects of different implant
surfaces on marginal bone levels alteration and did not
observe any evidence of improved marginal bone preser-
vation for any particular implant surface and configuration
modification.
However, one-piece morphology of zirconia dental
implants can influence marginal bone loss. In fact, it has
been proposed that periimplant marginal bone loss is more
extended around two-piece implants than around one-piece
implants as a result of the location of the microgap [27,
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28]. The presence of the microgap leads to bacterial leakage
and a microbial colonization of the gap at the bone level.
Periimplant soft tissues develop an inflammatory response
which promotes osteoclast formation and activation to result
in alveolar bone loss. Bone remodeling will progress until
the biologic width has been created and stabilized. Not only
does this width progress apically, along the vertical axis, but
according to studies conducted by Tarnow et al. [29] there is
also a horizontal component amounting to 1–1.5mm.
Furthermore, it is important to consider that plaque
accumulation on implant or abutment surface induces a
gingival inflammatory reaction [30] and consequently a
progressive bone loss [31]. In particular, roughness plays an
important role in the bacterial adhesion and this relationship
has been demonstrated in several in vivo and in vitro studies
[32, 33]. Scarano et al. [34] showed that zirconium oxide
presented a significant reduction of the presence of bacteria,
and Rimondini et al. [35] found that yttrium-stabilized
tetragonal zirconia surfaces accumulated significantly fewer
bacteria than titanium.
The reduced bacterial adhesion on zirconia implants
surface promotes early formation of the biologic width and
therefore the formation of a mucosal seal that stops early
marginal bone resorption [36–40].
5. Conclusions
Between the limits of this human clinical study, the following
could be stated.
(1) The crestal bone level of zirconia dental implants
suffers a slight reduction of 1.5mm after 4 years
followup and according to several studies, when
using a radiographic criterion for implant success,
marginal bone loss below 0.9–1.6mm during the
first year of function can be considered acceptable.
This periimplant bone preservationmay be associated
with the absence of microgap between fixture and
abutment since zirconia dental implants are one-piece
implants. Moreover, zirconia is characterized by a
high biocompatibility and it accumulates significantly
fewer bacteria than titanium.
(2) No bleeding, minimal plaque index of 0.5, and prob-
ing depth of 3.19mm could be expected in zirconia
dental implants.
(3) The absence of mobility with the previous param-
eters is the key of success criteria of zirconia den-
tal implants; due to these characteristics zirconia
implants may be considered as reliable as titanium
in terms of osseointegration and biological tissues
response.
The data reported in this study even if limited are encour-
aging. For this reason, further long-term clinical studies
regarding the success rates and clinical outcome of zirconia
dental implants are needed.
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